ISSN : 0970 - 020X, ONLINE ISSN : 2231-5039
     FacebookTwitterLinkedinMendeley

Synthesis of a New Conjugates of Imidazole wih Beta Lactam Moiety and Evaluation of its Expanded Antibacterial Activity

Sarmd D. Noori, Mazin N. Mousa and Shaker A. N. Al-Jadaan

Department of Pharmaceutical Chemistry, College of Pharmacy, University of Basrah, Basrah, Iraq.

Corresponding Author E-mail: sarmd18noori@gmail.com

DOI : http://dx.doi.org/10.13005/ojc/340535

Article Publishing History
Article Received on : 12-08-2018
Article Accepted on : 06-10-2018
Article Published : 17 Oct 2018
Article Metrics
ABSTRACT:

Five compounds containing (2,4,5-triphenyl triphenyl-1H-) and azetidinone (beta-lactam) moiety were synthesized. The physical data and yield of synthesized compounds were recorded, the chemical structure of prepared compounds were characterized using FT-IR, 1H-NMR and elemental analysis. The antibacterial activity was evaluated using disc diffusion method that involve tow Gram positive (staph. aureus, E. Faecalis), two Gram negative (E. coli and ‎K. pneumoniae), and one anaerobic bacteria (streptococcus. Pyogen). Different concentration of the prepared compounds has been used, and the obtained result were compared with standard (ceftazidime). Compound (5c) showed the best antibacterial activity against all bacterial species while 5a and 5e does not. Other compounds showed activity against some species.

KEYWORDS:

Aerobic; Anaerobic; Antibacterial; Beta Lactam; Imidazole

Download this article as: 

Copy the following to cite this article:

Noori S. D, Mousa M. N, Jadaan S. A. N. A. Synthesis of a New Conjugates of Imidazole wih Beta Lactam Moiety and Evaluation of its Expanded Antibacterial Activity. Orient J Chem 2018;34(5).


Copy the following to cite this URL:

Noori S. D, Mousa M. N, Jadaan S. A. N. A. Synthesis of a New Conjugates of Imidazole wih Beta Lactam Moiety and Evaluation of its Expanded Antibacterial Activity. Orient J Chem 2018;34(5). Available from: http://www.orientjchem.org/?p=50970


Introduction

Bacterial infection considered as one of the most serious problem that threaten the human life.1 So that, antibacterial field played an important role to save many human lives and contributed to the control of infectious diseases that considered as leading causes of human morbidity and mortality,2 Unfortunately, a considerable number and different types of the antibiotic agents are becoming less effective because of the spreading out of antimicrobial resistance. So, there is an urgent need for the synthesis and development of new antibacterial agents that have the ability to eradicate the resistant strains.3 That goal could be achieved by introduction of a new agents having more than one mechanism of action. So, if the microorganism develops a resistance technique to a certain mechanism, it will be still sensitive to the other one, and it is less likely to develop resistance to the all mechanisms.4 2,4,5-Triphenyl-1H-imidazole is a well-known compound containing five-member heterocyclic ring imidazole, it is excessively investigated for their antimicrobial activity, it is a versatile heterocyclic ring moiety having a wide range of biological activities.5 Imidazole present in many antiprotozoal and antibacterial drugs such as tinidazole and metronidazole and in antifungal drugs such as miconazole.6 Pharmaceutical applications of imidazole derivatives include, antibacterial activity, antifungal activity, anticancer activity, β-lactamase inhibitors activity, antiviral activity.7,8 Azetidinone-2-on (beta-lactam) moiety is present in many important antibacterial agents. It presents in penicillins, cephalosporins, and in the monobactam antibiotics. These groups of antibiotics have the beta-lactam moiety, and they show a well-known and powerful antibacterial actions.9 Both (2,4,5-triphenyl-1H-imidazole and beta-lactam) possess a well-documented antimicrobial activity, Therefore, it is reasonable to synthesize products having the two groups with enhanced potential antimicrobial activity.

Material and Methods

All chemicals were supplied by Merck KGaA, (Germany), Melting points were determined by Electrothermal 9300 digital melting point apparatus (UK), temperature resolution within 0.1°C. IR spectra of all compounds were recorded on FT-IR 8400S Shimadzu spectrophotometer (Japan) using KBr pellet. The 1H-NMR was recorded on Bruker Ultra shield -400MHz spectrometer (Switzerland) in DMSO-d6 by using TMS (Tetramethylsilane) as internal standard, chemical shifts were expressed as δ values (ppm). Elemental analysis of the prepared compounds was performed by Euro Vector EA 3000A (Italy) C, H, N, S elemental analyzer.

Synthetic Procedure of 2,4,5-Triphenyl-1H-Imidazole (1)

In a 500 mL round bottom flask equipped with magnetic bar, benzil (50 mmol) (10.5gm), benzaldehyde (50 mmol)(5.3gm) and excess ammonium acetate (250 mmol) (19.2gm) was dissolved in 200 mL acetic acid. The mixture was refluxed on the hot plate for 4 hour with stirring. The mixture then cooled to room temperature and it was filtered to remove any remaining precipitate. The filtrate was added into 250 mL of iced water and the pH of the mixture was neutralized with saturated sodium carbonate solution. The white precipitate was formed and it was collected by filtration under vacuum and recrystallized from ethanol and water. Yield 60%, melting point (287-290) °C (reported 292-295) °C.10

IR {KBR} cm-1: 3384 [N-H], 3074 [C-H aromatic], 1455 [C=C aromatic]

 Synthetic Procedures of 2,4,5-Triphenyl-1H-Imidazole-1-Carbonylchloride (2)

Accurately weighted 2,4,5-triphenyl-1-H-imidazole (30 mmol) (8.8 gm) was dissolved in 70 mL of acetone in conical flask. To this solution (60 mmol) (6.35 gm) of anhydrous sodium carbonate was added. A dropping funnel was fitted to the conical flask and in the dropping funnel a solution of (10 mmol) (1.12 gm) of chloroacetylchloride was taken. A very slow drop wise addition of chloroacetylchloride solution was done. The reaction mixture was stirred for 5-6 hours at cold condition. After 5-6 hours, excess of solvent and chloroacetylchloride was removed by distillation under reduced pressure and the residue was washed with aqueous sodium bicarbonate (5%w/v, 50 mL) and subsequently with cold water 50mL. The crude product was dried and recrystallization from ethanol to give white crystalline solid Yield 35%, melting point )151-153) °C IR {KBR} cm-1: 3070 [C-H aromatic], 2948 [C-H aliphatic], 1663 [C=O], 1578 [C=C aromatic], 744 [C-CL]

Synthetic Procedure of Hydrazine Derivatives, 2-Hydrazinyl-1-(2,4,5-Triphenyl-1H-Imidazole -1-Yl)Ethan-1-One (3)

In a conical flask, 2,4,5-triphenyl-1H-imidazole -1- carbonyl chloride (10 mmol) (3.72mg) was taken in acetone (20mL) and hydrazine hydrate (20 mmol, 80%) (1mg) was added to it. To this mixture (20 mmol) (2.11mg) of anhydrous sodium carbonate was added. The solution was stirred for stirred overnight, and then refluxed for 4h. The reaction mixture was cooled to room temperature and poured onto crushed ice with constant stirring. The solid formed was filtered and washed with water several times to remove excess of sodium carbonate. The product was recrystallized from ethanol: ether (1:3) to get off white powder. Yield 32% melting point (134-137) °C. IR {KBR} cm-1: 3481 [N-H], 3066 [C-H aromatic], 2933 [C-H aliphatic], 1646 [C=O], 1545 [C=C aromatic]

Synthesis of Schiff Base Derivatives (2-Hydrazinyl-1-(2,4,5-Triphenyl-1H-Imidazole -1-Yl)Ethan-1-One) (4 A-E )

The compound 3 (10 mmol) (3.70mg) was dissolve in 25 mL of absolute ethanol. To which a toluene para sulfonic acid (10 mmol) (1.72mg) was added. benzaldehyde derivatives (12 mmol) were added, and the reaction mixtures were refluxed for 6 h and left over night. A crystalline powder was formed which is collected by filtration under reduced pressure. The precipitate was washed with 5% sodium carbonate solution and then with D.W. The products were crystallized from hot ethanol. Yield, appearance in table (1).

4a”: IR {KBR} cm-1 :  3316 [N-H], 3057 [C-H aromatic], 2930 [ C-H aliphatic], 1662 [C=O], 1609 [C=N], 1500 [C=C aromatic]

“4b”: IR {KBR} cm-1 : 3392 [O-H], 3184 [N-H], 2975 [C-H aliphatic], 1685 [C=O], 1645 [C=N], 1504 [C=C aromatic]

“4c”: IR {KBR} cm-1 : 3384 [N-H], 3028 [C-H aromatic], 1685 [C=O], 1641 [C=N],

“4d”: IR {KBR} cm-1 : 3300 [N-H], 3054 [C-H aromatic], 2932 [C-H aliphatic], 1662 [C=O], 1609 [C=N],

“4e” : IR {KBR} cm-1: 3325 [N-H], 3028 [C-H aromatic], 1701 [C=O], 1641 [C=N]

Synthesis of [3-Chloro-1-((2-Oxo-2-(2,4,5-Triphenyl-1H-Imidazole -1-Yl)Ethyl)Amino)-4-Phenylazetidin-2-One] Derivatives (5 A-E)

A mixture of an appropriate Schiff base (10 mmol) (4.56 mg), and triethylamine (20 mmol) (2.02 mg) was dissolved in dry 1,4-dioxane 25 mL. To this mixture, a solution of α-chloroacetyl chloride (15 mmol) (1.69 mg) was added drop by drop with vigorous stirring at room temperature for 30 min. The reaction mixture was refluxed for 1 hour, and then the content was poured into crushed-ice. The solid precipitate was filtered and washed several times with water and recrystallized from hot ethanol, Yield, appearance in table (1). All data of elemental analysis [CHN] in table (2).

5a (R= H): melting point (124-126) °C; yield 21% ; pale yellow powder; IR {KBR} cm-1 : 3352 [N-H], 3051[C-H aromatic], 1670 [C=O], 2947 [ C-H aliphatic], 690 [C-Cl], 1442 [C=C aromatic], 1207 [C-N].

1H-NMR (DMSO) δ ppm; 4.33 [s, N-CH2 ], 4.72 [ d, C-CH], 5.11 [d, Cl-CH], 7.28- 8.14 [m, Ar-H].

5b (R= OH) : melting point (136-138)°C ; yield 18% ; white crystalline ; IR {KBR} cm-1 : 3350 [O-H], 3309 [N-H], 3066 [C-H aromatic], 1674 [C=O], 2931 [C-H aliphatic], 1442 [C=C], 690 [C-Cl].

1H-NMR (DMSO) δ ppm: 4.31[s, N-CH2], 4.78 [d, C-CH], 5.13 [d, CL-CH], 6.71-8.13 [m, Ar-H], 8.55 [s, O-H].

5c (R=OCH3) : melting point (139-143) °C ; yield 26% ; white crystalline ; IR {KBR} cm-1  : 3314 [N-H], 3052 [C-H aromatic], 1674 [C=O], 2851 [C-H aliphatic], 690 [C-Cl], 1442 [C=C],

1H-NMR (DMSO) δ ppm: 3.76 [s, O-CH3], 4.35 [s, N-CH2], 4.76 [d, C-CH], 5.15 [d, Cl-CH], 6.88-8.14 [ m, Ar-H].

5d (R=Cl) : melting point (122-124)°C; yield 30% ; yellow – white powder ; IR {KBR} cm-1 : 3396 [N-H], 3066 [C-H aromatic], 2931 [C-H aliphatic], 1675 [C=O], 960 [C-Cl],

1H-NMR (DMSO) δ ppm: 4.33 [s, N-CH2], 4,78 [d, C-CH], 5.14 [d, Cl-CH], 7.34-8.23 [m, Ar-H].

5e (R=NO2) : melting point (172-174) °C; yield 33% ; off-white powder ; ; IR {KBR} cm-1 : 3368 [N-H], 3051 [C-H aromatic], 2947 [C-H aliphatic].

1H-NMR (DMSO) δ ppm: 4.02 [s, N-CH3], 4.41 [d, C-CH], 4.82 [d, Cl-CH], 7.19-8.13 [m,ArH].

 

Scheme (1): Chemical Synthesis of the Desired Compounds.

Scheme 1: Chemical Synthesis of the Desired Compounds.



Click here to View scheme

 

Table 1: Physical data, melting points and percent yield of compound (4a-e) compound

Compound

Molecular formula

Yield %

description

Melting point  °C

Melting point reported [10]

  1

C21H16N2

60

White crystalline powder

292-295

292-295  °C

  2

C23H17ClN2O

35

White  crystalline powder

151-153

155  °C

  3

C23H20N4O

32

Off-white powder

134-137

4a

C30H24N4O

43

Yellow crystals , needle like shape

135-138

4b

C30H24N4O2

35

Reddish,  crystal powder

149-152

4c

C30H25N4O2

48

Yellow powder

161-164

4d

C30H23ClN4O

60

Dark yellow crystals flakes

110-112

4e

C30H23N5O3

52

Deep orange color,

Needle like shape

153-156

5a

C32H25ClN4O2

21

Pale yellow – off white powder

124-126

5b

C32H25ClN4O3

18

White crystalline powder

136-138

5c

C33H27ClN4O3

26

White crystal powder

139-142

5d

C32H24Cl2N4O2

30

Yellow _white powder

122-124

5e

C32H24ClN5O4

33

Off-white powder

172-174

 

The CHN analysis for the prepared compounds are with in ± 0.5 which confirmed the proposed structure of the prepared compounds.

Table 2: CHN analysis of compound (5a-e).

Compound 5

Molecular formula

Molecular weight

 

C

H

N

a

C32H25ClN4O2

533

Observed

71.69

4.70

11.00

Calculated

72.04

4.69

10.50

b

C32H25ClN4O3

549

Observed

70.38

4.49

10.70

Calculated

69.94

4.55

10.20

c

C33H27ClN4O3

563

Observed

70

4.67

10.33

Calculated

70.33

4.79

9.94

d

C32H24Cl2N4O2

567

Observed

67.95

4.17

10.12

Calculated

67.72

4.23

9.87

e

C32H24ClN5O4

578

Observed

66.30

4.23

12.60

Calculated

66.43

4.15

12.11

 

Antibacterial Activity

The inhibition of bacterial growth under suitable conditions may be used for determining the therapeutic efficacy of synthesized compounds, this method showed the ability of the prepared compound to inhibition of bacterial growth or not in compare with standard antibacterial agent. The in-vitro antibacterial activities of the synthesized compounds were carried out by disc diffusion method using prepared disc technique. Antibacterial activity of newly synthesized compound “5a-e” were screened against bacterial strains E. coli (E. coli, MTCC 2961), Staphylococcus aureus (S. aureus, MTCC 3160), enterococcus facaels, Klebsiella pneumoniae (K. pneumoniae, MTCC 3040) and anaerobic bacteria (Streptococcus. Pyogen).  The standard antibacterial compound was (ceftazidime).

Each one of the aerobic bacterial species inoculated  and spread on the surface of (Muller Hinton agar) by using a swap with uniform distribution pattern from different sides of petri dish to cover all upper surface of agar, six sterilized filter paper disc having diameter (6 mm), one disc represent the standard compound (ceftazidime), other five discs for prepared compound that immersed in specific concentration  solutions of  each compound “5a-e” applied with equal separated distance on the agar surface. Then incubate the prepared petri dish in a standardized incubation devise with setting temperature at 37 °C for 24 hours. After incubation period, the inhibition zone diameters for each disc were recorded, then compared with standard compound (ceftazedime) inhibition diameter. The results summarized in Table (3).

Anaerobic bacteria (Streptococcus. Pyogen) was spread on (Muller Hinton agar) in the same manner as above, but the petri dish was incubated in anaerobic conditions using tightly closed jar that empty from oxygen by using candle inside the jar, then the flame of candle extinguish after oxygen consumption. incubate the jar in incubator device at temperature 37°C for 24 hours, the antibacterial activity against anaerobic bacteria was evaluated in compare with standard compound. Result summarized in Table (3).

Result and Discussion

A series of compound “5a-e” have been successfully synthesized. The disc diffusion method was performed to evaluate the antibacterial activity for each of prepared compound. all the synthesized compounds were characterized by IR, 1H-NMR and CHN analysis, which agreed well with the proposed structure of prepared compounds.

aerobic bacterial species that used were, two Gram-negative (Enerococcus.coli and Klepsiella. pneumonia) and two Gram-positive (Staphylococcus. aureus and Enterococcus.faecalis) in addition to one anaerobic bacteria (Streptococcus. Pyogen). Compound “5a-e” showed variant antibacterial activity on the four aerobic bacterial species in compared to standard compound. Compound “5c” showed the best antibacterial activity against all four aerobic bacterial species, and showed the ability to effect on both Gram-positive and Gram-negative with greater effect on Gram-negative more than standard compound in the first concentration. While compound “5d” showed activity against E. coli and E.Faecalis bacteria species, without antibacterial activity against Staphylococcus.aureus  and Klepsiella.pneumonia, compound “5b” showed less antibacterial activity against  Klepsiella and  E.coli compare with compound 5 (c) that have good activity. Compound ” 5a” and “5e” did not show any antibacterial activity on all aerobic bacteria species. Compound “5b” and “5d” showed no effect on staphylococcus species. Compound “5b” showed some inhibition activity only in (0.5 and 0.25 mg/mL) concentration with no activity with (0.125mg/mL) concentration. Compound “5d” showed little activity only at the first concentration with no activity at second and third concentration. Compound “5e” without any activity at all three concentrations. Compound “5c” showed the best activity against anaerobic bacteria in compare to other compounds

By review the chemical structure of synthesized compounds will notice that all compound “5a-e” have the same core structure and differ only in substitution group on para position of  phenyl group that link to beta-lactam at C4 position, so any different in antibacterial activity is belong to this substitution, As a result  the substituted compounds containing electron donating groups like methoxy functional group are showed more antibacterial activity than electron withdrawing group like nitro and chloride group.10

The lipophilicity (hydrophobicity) of a compound is essential physical property that effect on the passive movement of compound through membrane, so that the lipophilic feature of molecule play important role in antibacterial activity.11-12 The octanol/water partition coefficient C logP is a measure of hydrophobicity/lipophilicity. The values of C log P were calculated using Chem Draw Ultra 8.0 software integrated with Cambridge Software (Cambridgesoft Corporation) obtained results shown in Table 4.

Table 3: Antibacterial activity of the prepared compounds

Compound

Concentration

mg/mL

Inhibition zone result diameter mm

S. aureus

Klebsiella

E.coli

E.Fecalis

S. pyogen

Standard

(CEFTAZIDIME)

0.5

 22

12

 10

15

24

0.25

 22

 12

 10

15

23

0.125

 22

 12

 10

15

23

5a

0.5

0.25

0.125

5b

0.5

6

6

17

0.25

6

2

13

0.125

5c

0.5

 23

20

30

42

37

0.25

19

 18

 25

30

30

0.125

 12

17

 19

20

20

5d

0.5

15

20

8

0.25

9

17

0.125

7

13

5e

0.5

0.25

0.125

 

Molar refractivity (MR), the measure of steric factor, bulkiness of the molecule and its polarizability13,14 was also calculated using Chem Draw Ultra 8.0 software integrated with Cambridge Software (Cambridgesoft Corporation). the compounds having greater values of both C Log P and molar refractivity showed better antimicrobial activity.16 Depend on previous theoretical issue, compound “5c” showed a high C Log P and higher molar refractivity (MR) that give its structure a good antibacterial activity.

These differences in cell wall structure can produce differences in the antibacterial susceptibility and some antibiotics which are effective against Gram-positive bacteria are found to be less or ineffective against Gram-negative bacteria.13-15 the outer membrane of the Gram-negative bacteria is less permeable than the cell walls of Gram-positives. Therefore synthesized compound “5c” showed better antibacterial activity towards Gram-positive bacteria specially (E.Faecalis ) than Gram-negatives, that made the movement of synthesized compound with high C logP through bacterial cell wall more easily, Also the substitution of OCH3 group at para position enhance the antibacterial activity.16

Table 4: Log P and molar refractore of compound 5 derivatives

COMPOUND 5

 C Log P

Molar refractory

a

7.13

153.06

b

6.4

154.88

c

7.01

160.31

d

7.8

157.67

e

6.88

144.88

 

By using 1H-NMR analysis to identification the synthesized compounds, all compound “5a-e” showed singlet band at range (4.02 – 4.35) δ ppm belong to proton in CH2 group that adjacent to(NH) with only one proton at nitrogen atom. Cyclic beta-lactam moiety has two proton in their structure, the first proton in cyclic bet-lactam observed at range (4.72 – 5.15) ppm, and present as doublet band due to effect of proton at adjacent (CH) group, second proton of (CH) group in cyclic beta-lactam moiety that bonded to chloride atom showed band range from (5.11 – 5.15) ppm higher than the first proton this due to proton near to an electronegative species are shifted “downfield” to higher δ values, all aromatic proton of 2,4,5-triphenyl imidazole observed above 6.71 ppm, with different splitting pattern depend on neighboring atom in same aromatic ring, most of them present at so close values, so appear on chart as overlap bands. compound “5c” chart showed a strong singlet band at 3.76 ppm, this band belongs to proton atom at (OCH3) that has zero proton at adjacent atom so appeared as a single band. Compound “5b” that have proton at OH group showed a single band at higher δ value 8.55 ppm, Signals for the proton in an O-H bond are not affected by hydrogen on adjacent atoms so are not split.

Conclusion

The newly synthesized compound “5a-e” showed a varying range of antibacterial activity. From the obtained results we can conclude that compound “5c” displayed the best antibacterial activity against both aerobic and anaerobic bacteria, and this may belong to presence of electron donating group (methoxy group) that has a good lipophilicity and high molar refractivity in addition to substituted at para position, so it will be the better candidate for further study and investigation to get more efficient compound.

Acknowledgement

Authors are thankful to Dr.Rahim jameel, Basrah university, department of pharmaceutical chemistry, and university of Thi-qar , department of microbiology, for providing all efforts to complete this work.

References

  1. Shahzadi, S.; Noshin, Z.; Saira, R.; Rehana, S.; Jawad N.; & Shahzad, N.; J. Nanomaterials. 2016, 6, 71
    CrossRef
  2. Rustam, I. A.; Front. Microbiol. 2010; 1: 134
  3. Jin X., Zheng C.J.; Song M.X.; Wu Y.;Sun L.P. Eur. J. Med. Chem. 2012,56, 203
    CrossRef
  4. Roberta,J.;  Worthington, M.; Christian, M.; Trends Biotechnol. 2013 March; 31(3): 177–184.
    CrossRef
  5. Starcevic, K.; Kralj, M.; Ester, K.; Sabol, I.; Grce, M.; Pavelic, K.; & Karminski-Zamola, G.; Bioorg Med Chem. 2007 Jul 1;15(13):4419-26.
    CrossRef
  6. Arunkumar, S. S.; Research Journal of Chemical Sciences. 2015. Vol. 5(10), 67-72.
  7. Zampieri, D.; Mamolo, MG.; Laurini, E.; Scialino. G.; Banfi, E.; & Vio, L. Bioorg. Med. Chem. 2008, 16: 4516.
    CrossRef
  8. Asif, H.; Nadeem. S.; MD, S.; Yasmin, K.; & Mohd, R. Acta Poloniae Pharmaceutica- Drug Research, 2011, Vol. 68 No. 5 pp. 657-663,
  9. Subin, M. Za.; Mridula. R, Namy, G.; Mohammad, S. A.; Int. J. Pharm. Sci. Rev. Res., 30(1), January – February 2015; Article No. 39, Pages: 211-218
  10. Shailesh, P.Z.; Badmanaban, R.; Dhrubo, J. S.; & Chhaganbhai, N. P, Journal of Applied Pharmaceutical Science 02 (07); 2012: 202-208
  11. Holla, B.S.; Malini, K.V.; Rao, B.S.; Sarojini, B.K.; Kumari, N.S; Eur. J. Med. Chem., 2003, 38, 313.
    CrossRef
  12. Chohan, Z.H.; Sumrra, S.H.; Youssoufi, M.H.; & Hadda, T.B. Eur. J. Med. Chem., 2010. 45, 2739,
    CrossRef
  13. Austel, V.; Kutter, Y.C.; Austel, E.; Marcel Dekker, V.; Eur. J. Drug Metab. Pharm. 1994, 3, 193.
  14. D.A. Smith, Design of drugs through a consideration of drug metabolism and pharmacokinetics. Eur. J. Drug Metab. Pharm., 3, 193, 1994
    CrossRef
  15. Maruyama, T.; Onda, K. M.; Hayakawa, N. S.; Takahashi, T.; Moritomo, H. T; Suzuki, T. Matsui.; Takasu, T. I.; Nagase, M. O. Med. Chem., 2009, 17, 3283.
    CrossRef
  16. Bipin, K. V.; Sunil, K.; Umesh K.; Savita, P.; & Priti, A.; Indian J. Pharm. Biol. Res. 2017; 5(1):1-9


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.